{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:49:32Z","timestamp":1790095772517,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-29789-3","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T17:04:44Z","timestamp":1763917484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A pilot study of re-purposing drugs to treat koalas with chlamydia"],"prefix":"10.1038","volume":"15","author":[{"given":"Charlotte","family":"Fleming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susel Loli","family":"Quinteros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bentotage S. M.","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel D. A.","family":"Tyndall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan K.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina S. A.","family":"Mella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelmina M.","family":"Huston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"key":"29789_CR1","unstructured":"Government, N. (2016). http:\/\/www.environment.nsw.gov.au\/animals\/TheKoala.htm."},{"key":"29789_CR2","unstructured":"The koala-. Saving our National Icon (Commonwealth of Australia, 2011)."},{"key":"29789_CR3","unstructured":"https:\/\/www.savethekoala.com\/our-work\/the-koala-is-worth-3-2-billion-30000-jobs\/"},{"key":"29789_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.vetmic.2013.02.026","volume":"165","author":"A Polkinghorne","year":"2013","unstructured":"Polkinghorne, A., Hanger, J. & Timms, P. Recent advances in Understanding the biology, epidemiology and control of chlamydial infections in Koalas. Vet. Microbiol. 165, 214\u2013223. https:\/\/doi.org\/10.1016\/j.vetmic.2013.02.026 (2013).","journal-title":"Vet. Microbiol."},{"key":"29789_CR5","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00252-20","author":"SP Ouellette","year":"2020","unstructured":"Ouellette, S. P., Lee, J. & Cox, J. V. Division without binary fission: cell division in the FtsZ-Less Chlamydia. J. Bacteriol. https:\/\/doi.org\/10.1128\/JB.00252-20 (2020).","journal-title":"J. Bacteriol."},{"key":"29789_CR6","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.femsre.2005.03.002","volume":"29","author":"YM Adbelrahman","year":"2005","unstructured":"Adbelrahman, Y. M. & Belland, R. J. The chlamydial developmental cycle. FEMS Microbiol. Rev. 29, 949\u2013959. https:\/\/doi.org\/10.1016\/j.femsre.2005.03.002 (2005).","journal-title":"FEMS Microbiol. Rev."},{"key":"29789_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/femsre\/fuaa024","volume":"44","author":"BL Quigley","year":"2020","unstructured":"Quigley, B. L. & Timms, P. Helping Koalas battle disease - Recent advances in chlamydia and Koala retrovirus (KoRV) disease Understanding and treatment in Koalas. FEMS Microbiol. Rev. 44, 583\u2013605. https:\/\/doi.org\/10.1093\/femsre\/fuaa024 (2020).","journal-title":"FEMS Microbiol. Rev."},{"key":"29789_CR8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/0300985817751218","volume":"55","author":"N Borel","year":"2018","unstructured":"Borel, N., Polkinghorne, A. & Pospischil, A. A. Review on chlamydial diseases in animals: still a challenge for pathologists? Vet. Pathol. 55, 374\u2013390. https:\/\/doi.org\/10.1177\/0300985817751218 (2018).","journal-title":"Vet. Pathol."},{"key":"29789_CR9","first-page":"496","volume-title":"Chlamydiosis in koalas","author":"M Jelocnik","year":"2019","unstructured":"Jelocnik, M., Gillett, A. & Hanger, J. Chlamydiosis in koalas 496\u2013506 (CSIRO Publishing, 2019)."},{"key":"29789_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.cbpc.2008.05.020","volume":"148","author":"BR Jones","year":"2008","unstructured":"Jones, B. R., El-Merhibi, A., Ngo, S. N. T., Stupans, I. & McKinnon, R. A. Hepatic cytochrome P450 enzymes belonging to the CYP2C subfamily from an Australian marsupial, the Koala (Phascolarctos cinereus). Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 148, 230\u2013237. https:\/\/doi.org\/10.1016\/j.cbpc.2008.05.020 (2008).","journal-title":"Comp. Biochem. Physiol. C: Toxicol. Pharmacol."},{"key":"29789_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2885.2011.01307.x","volume":"35","author":"M GOVENDIR","year":"2012","unstructured":"GOVENDIR, M. et al. Plasma concentrations of Chloramphenicol after subcutaneous administration to Koalas (Phascolarctos cinereus) with chlamydiosis. J. Vet. Pharmacol. Ther. 35, 147\u2013154. https:\/\/doi.org\/10.1111\/j.1365-2885.2011.01307.x (2012).","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"29789_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1365-2885.2010.01169.x","volume":"33","author":"JE GRIFFITH","year":"2010","unstructured":"GRIFFITH, J. E., HIGGINS, D. P., LI, K. M., GOVENDIR, M. & KROCKENBERGER, M. B. & Absorption of Enrofloxacin and Marbofloxacin after oral and subcutaneous administration in diseased Koalas (Phascolarctos cinereus). J. Vet. Pharmacol. Ther. 33, 595\u2013604. https:\/\/doi.org\/10.1111\/j.1365-2885.2010.01169.x (2010).","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"29789_CR13","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/jvp.12024","volume":"36","author":"LA Black","year":"2013","unstructured":"Black, L. A. et al. Pharmacokinetics of Chloramphenicol following administration of intravenous and subcutaneous Chloramphenicol sodium succinate, and subcutaneous Chloramphenicol, to Koalas (Phascolarctos cinereus). J. Vet. Pharmacol. Ther. 36, 478\u2013485. https:\/\/doi.org\/10.1111\/jvp.12024 (2013).","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"29789_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2885.2011.01307.x","volume":"35","author":"M Govendir","year":"2012","unstructured":"Govendir, M. et al. Plasma concentrations of Chloramphenicol after subcutaneous administration to Koalas (Phascolarctos cinereus) with chlamydiosis. J. Vet. Pharmacol. Ther. 35, 147\u2013154. https:\/\/doi.org\/10.1111\/j.1365-2885.2011.01307.x (2012).","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"29789_CR15","doi-asserted-by":"publisher","first-page":"e0209679","DOI":"10.1371\/journal.pone.0209679","volume":"13","author":"A Robbins","year":"2018","unstructured":"Robbins, A., Loader, J., Timms, P. & Hanger, J. Optimising the short and long-term clinical outcomes for Koalas (Phascolarctos cinereus) during treatment for chlamydial infection and disease. PLoS One. 13, e0209679. https:\/\/doi.org\/10.1371\/journal.pone.0209679 (2018).","journal-title":"PLoS One"},{"key":"29789_CR16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/avj.12364","volume":"93","author":"LA Black","year":"2015","unstructured":"Black, L. A., Higgins, D. P. & Govendir, M. In vitro activity of chloramphenicol, florfenicol and Enrofloxacin against chlamydia pecorum isolated from Koalas (Phascolarctos cinereus). Aust Vet. J. 93, 420\u2013423. https:\/\/doi.org\/10.1111\/avj.12364 (2015).","journal-title":"Aust Vet. J."},{"key":"29789_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fmicb.2019.00070","volume":"10","author":"S Phillips","year":"2019","unstructured":"Phillips, S., Quigley, B. L. & Timms, P. Seventy years of chlamydia vaccine Research - Limitations of the past and directions for the future. Front. Microbiol. 10, 70. https:\/\/doi.org\/10.3389\/fmicb.2019.00070 (2019).","journal-title":"Front. Microbiol."},{"key":"29789_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41541-024-00938-5","volume":"9","author":"S Phillips","year":"2024","unstructured":"Phillips, S. et al. Immunisation of Koalas against chlamydia pecorum results in significant protection against chlamydial disease and mortality. NPJ Vaccines. 9, 139. https:\/\/doi.org\/10.1038\/s41541-024-00938-5 (2024).","journal-title":"NPJ Vaccines"},{"key":"29789_CR19","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.3390\/jcm9072276","volume":"9","author":"M Cannon","year":"2020","unstructured":"Cannon, M. et al. Large-Scale drug screen identifies FDA-Approved drugs for repurposing in Sickle-Cell disease. J. Clin. Med. 9, 2276 (2020).","journal-title":"J. Clin. Med."},{"key":"29789_CR20","doi-asserted-by":"publisher","first-page":"31466","DOI":"10.1038\/srep31466","volume":"6","author":"A Lawrence","year":"2016","unstructured":"Lawrence, A. et al. Chlamydia Serine protease Inhibitor, targeting HtrA, as a new treatment for Koala chlamydia infection. Sci. Rep. 6, 31466. https:\/\/doi.org\/10.1038\/srep31466 (2016).","journal-title":"Sci. Rep."},{"key":"29789_CR21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/mmi.12306","volume":"89","author":"S Gloeckl","year":"2013","unstructured":"Gloeckl, S. et al. Identification of a Serine protease inhibitor which causes inclusion vacuole reduction and is lethal to chlamydia trachomatis. Mol. Microbiol. 89, 676\u2013689. https:\/\/doi.org\/10.1111\/mmi.12306 (2013).","journal-title":"Mol. Microbiol."},{"key":"29789_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.vetmic.2013.08.009","volume":"167","author":"A Kollipara","year":"2013","unstructured":"Kollipara, A. et al. Genetic diversity of chlamydia pecorum strains in wild Koala locations across Australia and the implications for a Recombinant C. pecorum major outer membrane protein based vaccine. Vet. Microbiol. 167, 513\u2013522. https:\/\/doi.org\/10.1016\/j.vetmic.2013.08.009 (2013).","journal-title":"Vet. Microbiol."},{"key":"29789_CR23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"29789_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2180-11-150","volume":"11","author":"A Amirshahi","year":"2011","unstructured":"Amirshahi, A. et al. Modulation of the chlamydia trachomatis in vitro transcriptome response by the sex hormones estradiol and progesterone. BMC Microbiol. 11, 150. https:\/\/doi.org\/10.1186\/1471-2180-11-150 (2011). doi:1471-2180-11-150 [pii].","journal-title":"BMC Microbiol."},{"key":"29789_CR25","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/mi.2016.22","volume":"9","author":"NE Quispe Calla","year":"2016","unstructured":"Quispe Calla, N. E. et al. Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection. Mucosal Immunol. 9, 1571\u20131583. https:\/\/doi.org\/10.1038\/mi.2016.22 (2016).","journal-title":"Mucosal Immunol."},{"issue":"Suppl 2","key":"29789_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1086\/652394","volume":"201","author":"PB Wyrick","year":"2010","unstructured":"Wyrick, P. B. Chlamydia trachomatis persistence in vitro: an overview. J. Infect. Dis. 201 (Suppl 2), 88\u201395. https:\/\/doi.org\/10.1086\/652394 (2010).","journal-title":"J. Infect. Dis."},{"key":"29789_CR27","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/biolre\/ioad021","volume":"108","author":"ER Bryan","year":"2023","unstructured":"Bryan, E. R. et al. Prophylactic and therapeutic vaccination protects sperm health from chlamydia muridarum-induced abnormalities. Biol. Reprod. 108, 758\u2013777. https:\/\/doi.org\/10.1093\/biolre\/ioad021 (2023).","journal-title":"Biol. Reprod."},{"key":"29789_CR28","doi-asserted-by":"publisher","first-page":"6505","DOI":"10.1016\/j.vaccine.2011.07.012","volume":"29","author":"A Carey","year":"2011","unstructured":"Carey, A. et al. A comparison of the effects of a chlamydial vaccine administered during or after a C. muridarum urogenital infection of female mice. Vaccine 29, 6505\u20136513. https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.012 (2011).","journal-title":"Vaccine"},{"key":"29789_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/icb.2009.3","volume":"87","author":"AJ Carey","year":"2009","unstructured":"Carey, A. J., Cunningham, K. A., Hafner, L. M., Timms, P. & Beagley, K. W. Effects of inoculating dose on the kinetics of chlamydia muridarum genital infection in female mice. Immunol. Cell. Biol. 87, 337\u2013343. https:\/\/doi.org\/10.1038\/icb.2009.3 (2009).","journal-title":"Immunol. Cell. Biol."},{"key":"29789_CR30","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.micinf.2012.07.017","volume":"14","author":"R Phillips Campbell","year":"2012","unstructured":"Phillips Campbell, R., Kintner, J., Whittimore, J. & Schoborg, R. V. Chlamydia muridarum enters a viable but non-infectious state in amoxicillin-treated BALB\/c mice. Microbes Infect. 14, 1177\u20131185. https:\/\/doi.org\/10.1016\/j.micinf.2012.07.017 (2012).","journal-title":"Microbes Infect."},{"key":"29789_CR31","doi-asserted-by":"publisher","first-page":"e3003123","DOI":"10.1371\/journal.pbio.3003123","volume":"23","author":"M Olander","year":"2025","unstructured":"Olander, M. et al. A multi-strategy antimicrobial discovery approach reveals new ways to treat chlamydia. PLoS Biol. 23, e3003123. https:\/\/doi.org\/10.1371\/journal.pbio.3003123 (2025).","journal-title":"PLoS Biol."},{"key":"29789_CR32","unstructured":"Bazroon, A. A. & Alrashidi, N. F. Bisoprolol. (2023)."},{"key":"29789_CR33","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/EJA.0b013e32833bf5e4","volume":"27","author":"M Mizogami","year":"2010","unstructured":"Mizogami, M., Takakura, K. & Tsuchiya, H. The interactivities with lipid membranes differentially characterize selective and nonselective beta1-blockers. Eur. J. Anaesthesiol. 27, 829\u2013834. https:\/\/doi.org\/10.1097\/EJA.0b013e32833bf5e4 (2010).","journal-title":"Eur. J. Anaesthesiol."},{"key":"29789_CR34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.2165\/00003495-198836030-00004","volume":"36","author":"PA 34 Todd","year":"1988","unstructured":"34 Todd, P. A., Ward, A. & Gemfibrozil A review of its pharmacodynamic and Pharmacokinetic properties, and therapeutic use in dyslipidaemia. Drugs 36, 314\u2013339. https:\/\/doi.org\/10.2165\/00003495-198836030-00004 (1988).","journal-title":"Drugs"},{"key":"29789_CR35","doi-asserted-by":"publisher","first-page":"22365","DOI":"10.1074\/jbc.M114.584185","volume":"289","author":"J Yao","year":"2014","unstructured":"Yao, J. et al. Type II fatty acid synthesis is essential for the replication of chlamydia trachomatis. J. Biol. Chem. 289, 22365\u201322376. https:\/\/doi.org\/10.1074\/jbc.M114.584185 (2014).","journal-title":"J. Biol. Chem."},{"key":"29789_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1186\/1471-2164-15-667","volume":"15","author":"NL Bachmann","year":"2014","unstructured":"Bachmann, N. L. et al. Comparative genomics of koala, cattle and sheep strains of chlamydia pecorum. BMC Genom. 15, 667. https:\/\/doi.org\/10.1186\/1471-2164-15-667 (2014).","journal-title":"BMC Genom."},{"key":"29789_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.meegid.2014.01.029","volume":"23","author":"A Nunes","year":"2014","unstructured":"Nunes, A. & Gomes, J. P. Evolution, phylogeny, and molecular epidemiology of chlamydia. Infect. Genet. Evol. 23, 49\u201364. https:\/\/doi.org\/10.1016\/j.meegid.2014.01.029 (2014).","journal-title":"Infect. Genet. Evol."},{"key":"29789_CR38","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.7150\/thno.56205","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria. Theranostics 11, 4910\u20134928. https:\/\/doi.org\/10.7150\/thno.56205 (2021).","journal-title":"Theranostics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29789-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29789-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29789-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:02:57Z","timestamp":1777395777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29789-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["29789"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29789-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45194"}}